The androgen receptor CAG repeat polymorphism as a risk factor of low serum testosterone and its cardiometabolic effects in men

International Journal of Andrology

Volumn 35, Issue 4, 2012, Pages 511-520

  Haring, R ^a   Ernst, F ^a   Schurmann, C ^a   Homuth, G ^a   Volker U ^a   Volzke H ^a   Nauck, M ^a   Wallaschofski, H ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

CAG repeat; Cardiometabolic risk factors; Longitudinal population based cohort; Metabolic syndrome; Testosterone

Indexed keywords

ANDROGEN RECEPTOR; TESTOSTERONE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CAG REPEAT; CARDIOMETABOLIC RISK; CONCENTRATION (PARAMETERS); CROSS-SECTIONAL STUDY; DNA POLYMORPHISM; FOLLOW UP; HUMAN; INCIDENCE; LINEAR SYSTEM; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; POISSON DISTRIBUTION; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; TESTOSTERONE BLOOD LEVEL;

ADULT; AGED; BODY COMPOSITION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DEHYDROEPIANDROSTERONE SULFATE; GERMANY; HEART; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ANDROGEN; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; TRINUCLEOTIDE REPEATS; YOUNG ADULT;

EID: 84863870397     PISSN: 01056263     EISSN: 13652605     Source Type: Journal    
DOI: 10.1111/j.1365-2605.2011.01220.x     Document Type: Article

References (43)

1. Alte D, Luedemann J, Rose HJ & John U. (2004) Laboratory markers carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume are not useful as screening tools for high-risk drinking in the general population: results from the study of health in Pomerania (SHIP). Alcohol Clin Exp Res 28, 931-940.
2. Crabbe P, Bogaert V, De Bacquer D, Goemaere S, Zmierczak H & Kaufman JM. (2007) Part of the interindividual variation in serum testosterone levels in healthy men reflects differences in androgen sensitivity and feedback set point: contribution of the androgen receptor polyglutamine tract polymorphism. J Clin Endocrinol Metab 92, 3604-3610.
3. Friedrich N, Volzke H, Rosskopf D, Steveling A, Krebs A, Nauck M & Wallaschofski H. (2008) Reference ranges for serum dehydroepiandrosterone sulfate and testosterone in adult men. J Androl 29, 610-617.
4. Friedrich N, Rosskopf D, Brabant G, Volzke H, Nauck M & Wallaschofski H. (2010) Associations of anthropometric parameters with serum TSH, prolactin, IGF-I, and testosterone levels: results of the study of health in Pomerania (SHIP). Exp Clin Endocrinol Diabetes 118, 266-273.
5. Giovannucci E, Stampfer MJ, Krithivas K, Brown M, Dahl D, Brufsky A, Talcott J, Hennekens CH & Kantoff PW. (1997) The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 94, 3320-3323.
6. Goutou M, Sakka C, Stakias N, Stefanidis I & Koukoulis GN. (2009) AR CAG repeat length is not associated with serum gonadal steroids and lipid levels in healthy men. Int J Androl 32, 616-622.
7. Gray A, Feldman HA, McKinlay JB & Longcope C. (1991) Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts male aging study. J Clin Endocrinol Metab 73, 1016-1025.
8. Guadalupe-Grau A, Rodriguez-Gonzalez FG, Dorado C, Olmedillas H, Fuentes T, Perez-Gomez J et al. (2010a) Androgen receptor gene polymorphisms lean mass and performance in young men. Br J Sports Med 45, 95-100.
9. Guadalupe-Grau A, Rodriguez-Gonzalez FG, Ponce-Gonzalez JG, Dorado C, Olmedillas H, Fuentes T, Perez-Gomez J, Sanchis-Moysi J, Diaz-Chico BN & Calbet JA. (2010b) Bone mass and the CAG and GGN androgen receptor polymorphisms in young men. PLoS ONE 5, e11529.
10. Haring R, Alte D, Volzke H, Sauer S, Wallaschofski H, John U & Schmidt CO. (2009a) Extended recruitment efforts minimize attrition but not necessarily bias. J Clin Epidemiol 62, 252-260.
11. Haring R, Volzke H, Felix SB, Schipf S, Dorr M, Rosskopf D, Nauck M, Schofl C & Wallaschofski H. (2009b) Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Pomerania. Diabetes 58, 2027-2031.
12. Haring R, Ittermann T, Volzke H, Krebs A, Zygmunt M, Felix SB, Grabe HJ, Nauck M & Wallaschofski H. (2010a) Prevalence, incidence and risk factors of testosterone deficiency in a population-based cohort of men: results from the study of health in Pomerania. Aging Male 13, 247-257.
13. Haring R, Volzke H, Steveling A, Krebs A, Felix SB, Schofl C, Dorr M, Nauck M & Wallaschofski H. (2010b) Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79. Eur Heart J 31, 1494-1501.
14. Haring R, Baumeister SE, Völzke H, Dorr M, Felix SB, Kroemer HK, Nauck M & Wallaschofski H. (2011) Prospective association of low total testosterone concentrations with an adverse lipid profile and increased incident dyslipidemia. Eur J Cardiovasc Prev Rehabil 18, 86-96.
15. Harman SM, Metter EJ, Tobin JD, Pearson J & Blackman MR. (2001) Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore longitudinal study of aging. J Clin Endocrinol Metab 86, 724-731.
16. Hersberger M, Muntwyler J, Funke H, Marti-Jaun J, Schulte H, Assmann G, Luscher TF & von Eckardstein A. (2005) The CAG repeat polymorphism in the androgen receptor gene is associated with HDL-cholesterol but not with coronary atherosclerosis or myocardial infarction. Clin Chem 51, 1110-1115.
17. Huhtaniemi IT, Pye SR, Limer KL, Thomson W, O'Neill TW, Platt H et al. (2009) Increased estrogen rather than decreased androgen action is associated with longer androgen receptor CAG repeats. J Clin Endocrinol Metab 94, 277-284.
18. Krithivas K, Yurgalevitch SM, Mohr BA, Wilcox CJ, Batter SJ, Brown M, Longcope C, McKinlay JB & Kantoff PW. (1999) Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men. J Endocrinol 162, 137-142.
19. Lee DM, Ulubaev A, Tajar A, Pye SR, Pendleton N, Purandare N et al. (2010) Endogenous hormones, androgen receptor CAG repeat length and fluid cognition in middle-aged and older men: results from the European male ageing study. Eur J Endocrinol 162, 1155-1164.
20. Muller M, den Tonkelaar I, Thijssen JH, Grobbee DE & van der Schouw YT. (2003) Endogenous sex hormones in men aged 40-80years. Eur J Endocrinol 149, 583-589.
21. Nielsen TL, Hagen C, Wraae K, Bathum L, Larsen R, Brixen K & Andersen M. (2010) The impact of the cag repeat polymorphism of the androgen receptor gene on muscle and adipose tissues in 20-29-year-old danish men: odense androgen study. Eur J Endocrinol 162, 795-804.
22. Nieschlag E & Behre H. (2004) Testosterone: Action, Deficiency, Substitution. University Press, Cambridge.
23. Page ST, Kupelian V, Bremner WJ & McKinlay JB. (2006) The androgen receptor gene CAG repeat polymorphism does not predict increased risk of heart disease: longitudinal results from the Massachusetts male ageing study. Clin Endocrinol (Oxf) 65, 333-339.
24. Pausova Z, Abrahamowicz M, Mahboubi A, Syme C, Leonard GT, Perron M, Richer L, Veillette S, Gaudet D & Paus T. (2010) Functional variation in the androgen-receptor gene is associated with visceral adiposity and blood pressure in male adolescents. Hypertension 55, 706-714.
25. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr & Vasan RS. (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27, 157-172; discussion 207-112.
26. Pocock SJ, McCormack V, Gueyffier F, Boutitie F, Fagard RH & Boissel JP. (2001) A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials. BMJ 323, 75-81.
27. Schipf S, Haring R, Friedrich N, Nauck MA, Lau K, Alte D, Stang A, Völzke H & Wallaschofski H. (2011) Low total testosterone is associated with increased risk of incident type 2 diabetes mellitus in men: results from the study of health in Pomerania (SHIP). Aging Male 14, 168-175.
28. Skjaerpe PA, Giwercman YL, Giwercman A & Svartberg J. (2009) Androgen receptor gene polymorphism and sex hormones in elderly men: the Tromso study. Asian J Androl 11, 222-228.
29. Skjaerpe PA, Giwercman YL, Giwercman A & Svartberg J. (2010) Androgen receptor gene polymorphism and the metabolic syndrome in 60-80years old Norwegian men. Int J Androl 33, 500-506.
30. Stanworth RD, Kapoor D, Channer KS & Jones TH. (2008) Androgen receptor CAG repeat polymorphism is associated with serum testosterone levels, obesity and serum leptin in men with type 2 diabetes. Eur J Endocrinol 159, 739-746.
31. Stanworth RD, Kapoor D, Channer KS & Jones TH. (2011) Dyslipidaemia is associated with testosterone, oestradiol and androgen receptor CAG repeat polymorphism in men with type 2 diabetes. Clin Endocrinol (Oxf) 74, 624-630.
32. Torkler S, Wallaschofski H, Baumeister SE, Völzke H, Dörr M, Felix SB, Rettig R, Nauck MA & Haring R. (2011) Inverse association between total testosterone concentrations, incident hypertension, and blood pressure. Aging Male 14, 176-182.
33. Travison TG, Shackelton R, Araujo AB, Morley JE, Williams RE, Clark RV & McKinlay JB. (2010) Frailty, serum androgens, and the CAG repeat polymorphism: results from the Massachusetts male aging study. J Clin Endocrinol Metab 95, 2746-2754.
34. Van Pottelbergh I, Lumbroso S, Goemaere S, Sultan C & Kaufman JM. (2001) Lack of influence of the androgen receptor gene CAG-repeat polymorphism on sex steroid status and bone metabolism in elderly men. Clin Endocrinol (Oxf) 55, 659-666.
35. Vermeulen A, Verdonck L & Kaufman JM. (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84, 3666-3672.
36. Volzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N et al. (2011) Cohort profile: the study of health in Pomerania. Int J Epidemiol 40, 294-307.
37. Walsh S, Zmuda JM, Cauley JA, Shea PR, Metter EJ, Hurley BF, Ferrell RE & Roth SM. (2005) Androgen receptor CAG repeat polymorphism is associated with fat-free mass in men. J Appl Physiol 98, 132-137.
38. Wu FC, Tajar A, Pye SR, Silman AJ, Finn JD, O'Neill TW et al. (2008) Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European male aging study. J Clin Endocrinol Metab 93, 2737-2745.
39. Zitzmann M. (2009) The role of the CAG repeat androgen receptor polymorphism in andrology. Front Horm Res, 37, 52-61.
40. Zitzmann M & Nieschlag E. (2003) The CAG repeat polymorphism within the androgen receptor gene and maleness. Int J Androl 26, 76-83.
41. Zitzmann M, Brune M, Kornmann B, Gromoll J, Junker R & Nieschlag E. (2001a) The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males. Clin Endocrinol (Oxf) 55, 649-657.
42. Zitzmann M, Brune M, Kornmann B, Gromoll J, von Eckardstein S, von Eckardstein A & Nieschlag E. (2001b) The CAG repeat polymorphism in the AR gene affects high density lipoprotein cholesterol and arterial vasoreactivity. J Clin Endocrinol Metab 86, 4867-4873.
43. Zitzmann M, Gromoll J, von Eckardstein A & Nieschlag E. (2003) The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men. Diabetologia 46, 31-39.